BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements


You May Also Like

Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough

PLYMOUTH MEETING, Pa., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update

Key Highlights: Entered into a global immuno-oncology agreement in April 2018 with Boehringer Ingelheim ...